Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M27,416Revenue (TTM) $M1,702Net Margin (%)-6.6Altman Z-Score7.8
Enterprise Value $M26,704EPS (TTM) $-0.5Operating Margin %0.6Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-4.0Higher ROA y-yY
Price/Book25.310-y EBITDA Growth Rate %--Quick Ratio2.2Cash flow > EarningsY
Price/Sales16.95-y EBITDA Growth Rate %--Current Ratio2.3Lower Leverage y-yY
Price/Free Cash Flow161y-y EBITDA Growth Rate %--ROA % (ttm)-4.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-11.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M248ROIC % (ttm)3.1Gross Margin Increase y-yN

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

VRTX is held by these investors:



VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Chodakewitz JeffreyEVP GMDA, CMO 2017-04-05Sell8,021$1143.31view
Chodakewitz JeffreyEVP GMDA, CMO 2017-04-03Sell2,291$108.858.19view
Silva Paul MSVP & Corp Controller 2017-03-29Sell1,688$106.310.79view
Sachdev AmitEVP, CRO 2017-03-29Sell80,500$107.639.42view
Chodakewitz JeffreyEVP GMDA, CMO 2017-03-29Sell13,750$106.6510.43view
SMITH IAN FEVP, CFO & COO 2017-02-28Sell3,842$9030.86view
Arbuckle Stuart AEVP\Chief Commercial Officer 2017-02-13Sell3,792$88.3933.24view
ALTSHULER DAVIDEVP, Global Research and CSO 2017-02-13Sell6,403$87.6834.32view
LEIDEN JEFFREY MCEO & President 2017-02-13Sell23,904$87.6834.32view
Sachdev AmitEVP, CRO 2017-02-13Sell7,684$87.6834.32view

Quarterly/Annual Reports about VRTX:

    News about VRTX:

    Articles On GuruFocus.com
    Galapagos NV Tests Cystic Fibrosis Treatment on First Patient Feb 03 2017 
    Galapagos NV Announces Results From Cystic Fibrosis Treatment Study Dec 27 2016 
    Piotroski F-Score in the Real World Dec 19 2016 
    Testing of Treatment for Cystic Fibrosis Patients Begins Nov 29 2016 
    Edward Owens Top 2nd Quarter Investments Aug 03 2016 
    Vanguard Health Care Fund Ups Stake in High-Conviction Stocks May 10 2016 
    Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
    Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
    Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter May 20 2015 
    Analysts Confident That Vertex Pharmaceuticals' CF Drug Will Receive FDA Approval May 13 2015 

    More From Other Websites
    What's in Store for Vertex (VRTX) this Earnings Season? Apr 24 2017
    3 Healthcare Bargain Stocks You Can Buy Right Now Apr 24 2017
    3 Stocks That Growth Investors Should Love Apr 23 2017
    Trump invites ​Vertex CEO to White House for biotech summit Apr 21 2017
    ​Vertex at odds with religious investors over lobbying disclosures Apr 18 2017
    Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex... Apr 18 2017
    ​Vertex CEO's compensation, stock value fell in 2016 Apr 17 2017
    Retirement Accounts Benefit From Columbia Fund's Tech Bets Apr 13 2017
    Vertex to Announce First Quarter 2017 Financial Results on April 27 Apr 12 2017
    Protalix Cystic Fibrosis Drug Study Results Worsen Over Time Apr 12 2017
    3 Best Performing Stocks in March Apr 10 2017
    What's Next for Corbus Pharmaceuticals After Its Controversial Cystic Fibrosis Results? Apr 08 2017
    The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar... Apr 07 2017
    3 Great Stocks on Sale to Buy Today Apr 07 2017
    15 companies with outsized sales growth and widening profit margins Apr 07 2017
    3 Top Stocks to Buy in Q2 Apr 06 2017
    Greenbrier And Vertex Maintain Bullish Bias, Stamps.com Breaking Down Apr 06 2017
    Stocks To Watch In Market Weakness Apr 06 2017
    Harry Boxer’s four stocks to watch Apr 06 2017
    Vertex Pharmaceuticals (VRTX) Shares March Higher, Can It Continue? Apr 06 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)